PCAS

Registration Form • Apr 29, 2022

RELEASE OF THE 2021 UNIVERSAL REGISTRATION DOCUMENT (URD)

Ecully, April 29, 2022

The PCAS Universal Registration Document 2021, which includes the annual financial report, was filed with France's Financial Markets Authority, in ESEF format (European Single Electronic Format), on April 29, 2022, under number D.22-0386.

This document contains:

• The 2021 annual financial report
• The Board of Directors' corporate governance report in accordance with Section L.225-37 of France's Commercial Code
• Information on the statutory auditors' fees

This document is now available:

• At PCAS headquarters: 21 chemin de la Sauvegarde, 21 Ecully Parc, CS 33167, 69134 Ecully, France
• On the company website: www.pcas.com

NEXT FINANCIAL DISCLOSURE:

2021 Shareholder's Meeting in Ecully at 10 a.m. on June 9, 2022

ABOUT PCAS

PCAS specializes in the development and production of complex molecules for life sciences and innovative technologies. With about 12% of its net sales earmarked for R&D and a large international footprint, PCAS is the preferred industrial partner for market-leading major global groups. Boasting especially high standards, the company offers a growing range of proprietary products and solutions in leading-edge segments. PCAS generated net sales of €187.0 million in 2021 and employs nearly 1200 people in six countries.

To find out more about PCAS: www.pcas.com

PCAS	Newcap
Philippe Clavel / Eric Moissenot	Emmanuel Huynh / Louis-Victor Delouvrier Financial communication and investor relations
Tél. : +33 1 69 79 60 00 www.pcas.com	Tél. : +33 1 44 71 98 53 pcas@newcap.eu

Page 1